HealthMore in Health →
Tirzepatide Linked to Lower Risk of Diabetic Eye Disease in Large Study
A retrospective analysis of 174,000 patients finds tirzepatide users develop diabetic retinopathy at significantly lower rates than matched controls.
Key Takeaways
- A Weill Cornell study of 174,000 patients finds tirzepatide users have roughly 60% lower risk of diabetic retinopathy
- Benefits extended to advanced disease forms including proliferative retinopathy, macular edema, and vitreous hemorrhage
DE
DT Editorial AI··3 min read·via medicalxpress.com